다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Avadel Pharmaceuticals PLC (AVDL)
Avadel Pharmaceuticals PLC (AVDL) 뉴스

AVDL

Avadel Pharmaceuticals (AVDL)

Avadel Pharmaceuticals PLC

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AVDL

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/05/02	04:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/05/02	03:10	Dow Jones News	Avadel Pharmaceuticals Gets Final FDA Approval for Narcolepsy Treatment Lumryz	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/05/02	02:20	GlobeNewswire Inc.	Avadel Pharmaceuticals Announces Final FDA Approval of LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension as the First and Only Once-at-Bedtime Oxybate for Cataplexy or Excessive Daytime Sleepiness in Adults with Narcolepsy	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/04/29	05:29	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/04/29	05:11	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/04/21	05:05	GlobeNewswire Inc.	Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/04/10	21:00	GlobeNewswire Inc.	Avadel Pharmaceuticals to Present at the 22nd Annual Needham Healthcare Conference	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/04/05	20:33	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/04/04	06:29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/04/04	05:05	GlobeNewswire Inc.	Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/31	06:09	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/30	20:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/30	20:00	GlobeNewswire Inc.	Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/30	10:27	GlobeNewswire Inc.	Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 30	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/30	10:24	GlobeNewswire Inc.	Avadel Pharmaceuticals Announces Pricing of Public Offering of ADSs and Series B Preferred Shares	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/30	06:02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/30	05:13	GlobeNewswire Inc.	Avadel Pharmaceuticals Announces Proposed Underwritten Public Offering of ADSs and Series B Preferred Shares	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/30	05:10	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/30	05:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/30	05:01	GlobeNewswire Inc.	Avadel Pharmaceuticals Enters into Royalty Agreement with RTW Investments for up to $75 Million	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/22	20:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/22	20:00	GlobeNewswire Inc.	Avadel Pharmaceuticals Announces FDA Authorization to Import Tentatively-Approved LUMRYZ™ Ahead of Anticipated Final Approval Decision	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/22	05:05	GlobeNewswire Inc.	Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/10	06:14	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/02	21:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/03/02	21:00	GlobeNewswire Inc.	Avadel Pharmaceuticals Requests Final FDA Approval for LUMRYZ™ (sodium oxybate) extended-release oral suspension	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/02/25	03:47	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/02/17	06:05	GlobeNewswire Inc.	Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/02/15	06:08	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC
2023/02/15	00:02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AVDL	Avadel Pharmaceuticals PLC

검색 관련기사 보기:NASDAQ:AVDL

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 다음 >>

Health Care Select Sector

Bank of America

Energy Select Sector SPDR

JP Morgan Chase

Financial Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관